Gene · 1399
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell RNA analysis to identify five cytokines signaling in immune-related genes for melanoma survival prognosis. | Front Immunol | 2023 | 37026000 | PubTator, text mining | PubMed |
| A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology. | Ther Adv Med Oncol | 2023 | 37025260 | PubTator, text mining | PubMed |
| Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer. | Front Endocrinol (Lausanne) | 2023 | 37020597 | PubTator, text mining | PubMed |
| Analyses of thymocyte commitment to regulatory T cell lineage in thymus of healthy subjects and patients with 22q11.2 deletion syndrome. | Front Immunol | 2023 | 37006241 | PubTator, text mining | PubMed |
| Single-cell epitope-transcriptomics reveal lung stromal and immune cell response kinetics to nanoparticle-delivered RIG-I and TLR4 agonists. | Biomaterials | 2023 | 37001347 | PubTator, text mining | PubMed |
| PROTAC'ing oncoproteins: targeted protein degradation for cancer therapy. | Mol Cancer | 2023 | 36991452 | PubTator, text mining | PubMed |
| Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes. | Nat Commun | 2023 | 36991000 | PubTator, text mining | PubMed |
| Integration of Transcriptomics and Non-Targeted Metabolomics Reveals the Underlying Mechanism of Skeletal Muscle Development in Duck during Embryonic Stage. | Int J Mol Sci | 2023 | 36982289 | PubTator, text mining | PubMed |
| Language Profiles of School-Aged Children with 22q11.2 Copy Number Variants. | Genes (Basel) | 2023 | 36980951 | PubTator, text mining | PubMed |
| Analysis of Cancer Genomic Amplifications Identifies Druggable Collateral Dependencies within the Amplicon. | Cancers (Basel) | 2023 | 36980521 | PubTator, text mining | PubMed |
| A systematic evaluation of deep learning methods for the prediction of drug synergy in cancer. | PLoS Comput Biol | 2023 | 36952569 | PubTator, text mining | PubMed |
| Deep thermal profiling for detection of functional proteoform groups. | Nat Chem Biol | 2023 | 36941476 | PubTator, text mining | PubMed |
| Relationship between tumor microbiota transcriptional activity and gene expression in breast cancer. | BMC Cancer | 2023 | 36927310 | PubTator, text mining | PubMed |
| A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine. | J Clin Med | 2023 | 36902723 | PubTator, text mining | PubMed |
| Targeting lung cancer brain metastases: a narrative review of emerging insights for anaplastic lymphoma kinase (ALK)-positive disease. | Transl Lung Cancer Res | 2023 | 36895918 | PubTator, text mining | PubMed |
| LRRC75A-AS1 delivered by M2 macrophage exosomes promotes cervical cancer progression via enhancing SIX1 expression. | Cancer Sci | 2023 | 36892427 | PubTator, text mining | PubMed |
| Insufficiency of Mrpl40 disrupts testicular structure and semen parameters in a murine model. | Asian J Androl | 2023 | 36891938 | PubTator, text mining | PubMed |
| Induction of DNMT1-dependent demethylation of SHP-1 by the natural flavonoid compound Baicalein overcame Imatinib-resistance in CML CD34+ cells. | Cell Commun Signal | 2023 | 36869331 | PubTator, text mining | PubMed |
| Benchmarking of Machine Learning classifiers on plasma proteomic for COVID-19 severity prediction through interpretable artificial intelligence. | Artif Intell Med | 2023 | 36868685 | PubTator, text mining | PubMed |
| The Hedgehog/GLI signaling pathway activates transcription of Slug (Snail2) in melanoma cells. | Oncol Rep | 2023 | 36866769 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1399/papers?page=11